Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+10.25%
Latest
-1.16%
3 months
SEBDNBPareto SecuritiesDanske Bank MarketsDNB MarketsSEB EquitiesCarnegieBryan GarnierDanske Bank

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
SEB500 SEKMay 29
+10.25%
DNB468 SEKApr 26
Pareto Securities420 SEKApr 25
Danske Bank Markets405 SEKApr 15
DNB Markets418 SEKJan 29
SEB Equities390 SEKJan 26
Carnegie350 SEKJan 26
Bryan Garnier340 SEKNov -23
Danske Bank403 SEKOct -22

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion